SARS-CoV-2-specific humoral and cellular immune responses to BNT162b2 vaccine in Fibrodysplasia ossificans progressiva patients.

Jitka Smetanova,Tomas Milota,Michal Rataj,Jana Hurnakova,Hana Zelena,Rudolf Horvath

Frontiers in immunology（2022）

引用 1|浏览3

暂无评分

摘要

The BNT162b2 vaccine induced high humoral and cellular response levels in patients with FOP. Vaccination was not associated with SAE or disease relapse. The AEs spectrum was comparable to that of the general population.

查看译文

关键词

COVID-19,SARS-CoV-2,fibrodysplasia ossificans progressive,immunogenicity,safety,vaccination

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要